Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Items 401–500 of 698
Wu, K. A., Kim, J. K., Rosser, M. A., Chow, B., Bottiger, B., & Klapper, J. A. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-02952-z · Cited by 8
“Diamond et al., in a multicenter study comprised of 1,255 lung LT recipients across 10 different centers found that the use of over one liter of PRBCs was associated with severe PGD at 48 to 72 h postoperatively [28].”
BackgroundLung allograft dysbiosis associates with immune response and primary graft dysfunction
Nelson, N. C., Wong, K. K., Mahoney, I. J., Malik, T., Rudym, D., Lesko, M. B., Qayum, S., Lewis, T. C., Chang, S. H., Chan, J. C. Y., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.11.006 · Cited by 7
Benazzo, A., Peel, J. K., Mariscal, A., Yeung, J. C., Aversa, M. M., Keshavjee, S. H., & Cypel, M. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.08.002 · Cited by 8
New Techniques for Optimization of Donor Lungs/Hearts
Braithwaite, S. A., & van der Kaaij, N. P. (2019) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.08.010 · Cited by 6
Postoperative management and acute complications after lung transplantation
Haddad, O. K., & Thomas, M. (2021) · Current Challenges in Thoracic Surgery · doi:10.21037/ccts-20-182 · Cited by 8
Stoker, A. D., Hicks, A. C., Wright, M. C., Ali, H. A., Klapper, J. A., Poisson, J. L., Zaffiri, L., Chen, D., Hartwig, M. G., Ghadimi, K., et al. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.04.038 · Cited by 6
Di, Y., Fu, R., Xiang, Z., Sun, H., Dai, M., Zhang, Q., & Si, Y.-X. (2024) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.ra.24-00092 · Cited by 6
“29) In contrast, the research of Diamond et al. concluded that there was no association between donor age and PGD. 30) Some studies have alternatively concluded that it is not donor age alone that contributes to the development of PGD, but rather the interaction between recipient and donor factors…”
Lansink‐Hartgring, A. O., Hessels, L., de Vries, A. J., van der Bij, W., Verschuuren, E. A. M., Erasmus, M. E., & Nijsten, M. W. (2018) · Annals of Transplantation · doi:10.12659/aot.909484 · Cited by 6
“After standardization of the definition of PGD in 2005 by the International Society for Heart and Lung Transplantation (ISHLT), risk factors for grade 3 PGD were: receipt of an organ from a donor with any smoking history, elevated FiO2 during reperfusion, preoperative diagnosis of sarcoidosis, use of cardiopulmonary b…”
MethodYoon, J., & Salamanca-Padilla, Y. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000811 · Cited by 7
“Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.”
BackgroundInfluentialNew strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertension
Ohsumi, A., Aoyama, A., Kinoshita, H., Yoneda, T., Yamazaki, K., Tanaka, S., Nakajima, D., Ikeda, T., Minatoya, K., & Date, H. (2022) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-021-01746-7 · Cited by 6
“In addition, Porteous et al. found that differences in left ventricular diastolic function may contribute to the development of PGD [3].”
BackgroundInfluentialLi, J., Han, Z., Zhu, Z., & Wei, L. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.06.015 · Cited by 6
Lung transplantation in pulmonary sarcoidosis
Kim, J. S., & Gupta, R. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103135 · Cited by 6
Bottiger, B., Klapper, J. A., Fessler, J., Shaz, B. H., & Levy, J. H. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004829 · Cited by 8
“11 In other single-center studies in lung transplantation, massive transfusion was defined as an intraoperative erythrocyte unit requirement more than 5 U, 25 and another defined it as more than 10 U in 24 h. 26 A summary of published measures and definitions of bleeding applicable to lung…”
BackgroundInfluentialMoazed, F., Hendrickson, C. M., Nelson, M. F., Conroy, A., Cohen, M. J. M., & Calfee, C. S. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001738 · Cited by 6
“In critically ill blunt trauma patients, active and passive cigarette smoke exposure have been associated with an increased risk of ARDS (1); likewise, smoking is associated with an increased risk of ARDS in non-pulmonary sepsis (2) and following blood transfusion (3), as well as with primary graft dysfunction (4), a…”
Diamond, J. M., Ramphal, K., Porteous, M. K., Cantu, E., Christie, J. D., & Kawut, S. M. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.12.012 · Cited by 6
Self-citationSantambrogio, L., Tarsia, P., Mendogni, P., & Tosi, D. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.166 · Cited by 7
Dysregulated alveolar function and complications in smokers following oesophagectomy
Lugg, S. T., Alridge, K. A., Howells, P. A., Parekh, D., Scott, A., Mahida, R. Y., Park, D., Tucker, O., Gao, F., Perkins, G. D., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00089-2018 · Cited by 6
Pulmonary Hypertension and Right Ventricular Failure
Huston, J., Brittain, E. L., & Robbins, I. M. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.01.002 · Cited by 10
Hayde, N. A. (2020) · Pediatric Transplantation · doi:10.1111/petr.13877 · Cited by 6
Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs
Ojanguren, A., Santamaría, M., Collado, L. M., Fraile, C., Gatius, S., Puy, S., Boldó, A., Gómez‐Ollés, S., Boada-Pérez, M., Esquinas, C., et al. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2021.03.015 · Cited by 6
Fessler, J., Finet, M., Fischler, M., & Guen, M. L. (2022) · Life · doi:10.3390/life13010092 · Cited by 10
“A grade 3 PGD at 72 h is associated with an increased risk of 90-day and 1-year mortality [61].”
BackgroundWeng, G., Zhao, J., Zhu, X., Chen, Y., Zhang, C., & Gong, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07360-y · Cited by 5
“It seriously impairs patient prognosis and endangers life safety [1–3].”
Advanced Pulmonary Sarcoidosis
Spagnolo, P., Dhanani, Z., Cameli, P., Fiorentù, G., & Gupta, R. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2768-2520 · Cited by 5
“82,112 In addition, preoperative PH is common in advanced sarcoidosis and is an independent risk factor for PGD. 112,114 However, their long-term outcomes are comparable to those of transplant recipients with other underlying diseases.”
Lung Transplantation for Pulmonary Hypertension
Frick, A. E., & Höetzenecker, K. (2021) · Organ and tissue transplantation · doi:10.1007/978-3-319-20788-9_11-1 · Cited by 5
Veraar, C., Kirschner, E., Schwarz, S., Jaksch, P., Höetzenecker, K., Tschernko, E., Dworschak, M., Ankersmit, H. J., & Moser, B. (2022) · Biology · doi:10.3390/biology11101475 · Cited by 6
“In a prospective multicenter cohort study on 1225 patients, transfusion of more than 1 L of PRBCs was associated with a nearly 2-fold increased risk of developing PGD grade 3 [30].”
BackgroundCharacterizing Rational Transplant Program Response to Outcome-Based Regulation
Mildebrath, D., Lee, T., Sinha, S., Schaefer, A. J., & Gaber, A. O. (2023) · Operations Research · doi:10.1287/opre.2018.0721 · Cited by 5
“Although an exceptionally low-quality graft may adversely affect transplant outcomes, a large majority of the clinical factors associated with graft failure in lung transplantation depend mainly on the physiology of the recipient (Diamond et al. 2013).”
BackgroundBennett, R. M., Reilly, J. P., Diamond, J. M., Cantu, E., Shashaty, M. G. S., Benvenuto, L. J., Singer, J. P., Palmer, S. M., Christie, J. D., & Anderson, M. R. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100107 · Cited by 5
Self-citationXu, X., Lou, Z., Li, J., Liang, F., Yu, Y., & Wu, M. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70037 · Cited by 5
Schiavon, M., Marulli, G., Rebusso, A., Calabrese, F. A., Gregorio, G. D., Serra, E., Loy, M., Lunardi, F., Calabrese, F., & Rea, F. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.10.015 · Cited by 5
Chronic Obstructive Pulmonary Disease and Lung Transplantation
Greer, M., & Welte, T. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1714250 · Cited by 5
Banga, N., & Mohanka, M. R. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.08.055 · Cited by 5
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction
Yuenger, V., January, S. E., Fester, K. A., McCloskey, M. M., & Hachem, R. R. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2770 · Cited by 5
Veno-venous extracorporeal membrane oxygenation for the treatment of respiratory compromise
Ndubisi, N. M., & van Berkel, V. H. (2023) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-022-01467-3 · Cited by 5
“This devastating clinical circumstance is thought to occur in 15–30% of all lung transplants (LTx) [36, 37].”
BackgroundAggarwal, R., Potel, K. N., Jackson, S., Lemke, N. T., Kelly, R. F., Soule, M., Diaz‐Gutierrez, I., Shumway, S. J., Patil, J., Hertz, M. I., et al. (2023) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2023.09.031 · Cited by 5
Shah, K. B., Erp, J. M. K., Migliore, C., Orr, Y., Corris, P. A., Glanville, A. R., Slaughter, M. S., West, L. J., & Mehra, M. R. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.11.011 · Cited by 5
Survey of Lung Transplant Community’s Views on Primary Graft Dysfunction
Diamond, J. M., Shah, R., Cantu, E., Porteous, M. K., & Christie, J. D. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13552 · Cited by 5
“The reported incidence of PGD fell within the incidence of severe PGD in clinical research (3,4).”
Self-citationPredicting Primary Graft Dysfunction After Lung Transplantation
Diamond, J. M. (2016) · Transplantation · doi:10.1097/tp.0000000000001523 · Cited by 5
Self-citationElevated donor plasminogen activator inhibitor‐1 levels and the risk of primary graft dysfunction
Hamilton, B. C. S., Dincheva, G. R., Zhuo, H., Golden, J. A., Brzeziński, M., Singer, J. P., Matthay, M. A., & Kukreja, J. (2018) · Clinical Transplantation · doi:10.1111/ctr.13210 · Cited by 5
A Retrospective Cohort Study of Risk Factors for Surgical Site Infection Following Lung Transplant
Moraes, J. L. S., Oliveira, R. A., Samano, M. N., & Poveda, V. D. B. (2020) · Progress in Transplantation · doi:10.1177/1526924820958133 · Cited by 5
“Donor smoking is related to primary graft dysfunction and a higher risk of long-term mortality in the recipient.(23,24) It is possible that cigarette smoking could alter the development and production of cytokines as well as contribute to dysfunction of innate immune cells and adaptative immune cells in the recipient.”
BackgroundManaging pulmonary arterial hypertension: how to select and facilitate successful transplantation
Khangoora, V. S., King, C. S., & Shlobin, O. A. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000980 · Cited by 7
The Effect of Prone Positioning After Lung Transplantation
Frick, A. E., Schiefer, J., Maleczek, M., Schwarz, S., Benazzo, A., Rath, A., Kulu, A., Hritcu, R., Faybik, P., Schaden, E., et al. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2023.04.036 · Cited by 5
“Intraoperative transfusions - Units packed red blood cells (median; IQR) 4 (2-7) 4 (3-7) 4 (2-6) *0.”
BackgroundInfluentialSinger, J. P. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201706-480ed · Cited by 5
Ware, L. B. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.11.013 · Cited by 5
Self-citationOutcomes of Donor/Recipient Size-mismatched Lung Transplantation
Park, B. S., Kim, D. J., Lee, C. Y., Park, B. J., Kim, H. E., Yang, Y. H., Park, M. S., Kim, S. Y., Woo, A., Kim, E. Y., et al. (2025) · Transplantation Proceedings · doi:10.1016/j.transproceed.2025.04.008 · Cited by 4
Self-citationSingh, J. P., Meng, X., Leader, J. K., Ryan, J. P., Pu, L., Deitz, R. L., Chan, E. G., Shigemura, N., Hage, C. A., Sánchez, P. G., et al. (2025) · Clinical Transplantation · doi:10.1111/ctr.70217 · Cited by 4
Todd, J. L., Neely, M. L., Hsu, J. Y., Diamond, J. M., Anderson, M. R., Cantu, E., Clausen, E. S., Pandya, K., Oyster, M. L., Kalman, L., et al. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamaf055 · Cited by 5
Self-citationAlderete, I. S., Medina, C. K., Pontula, A., Halpern, S. E., Soto, A. L., Patel, K., Klapper, J. A., & Hartwig, M. G. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.10.045 · Cited by 4
Right ventricle free wall longitudinal strain screening of lung transplant candidates
Scaravilli, V., Scansani, S., Meani, P., Turconi, G., Guzzardella, A., Bosone, M., Bonetti, C., Vicenzi, M., Morlacchi, L. C., Rossetti, V., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314235 · Cited by 4
Current challenges in lung transplantation
Niroomand, A., & Lindstedt, S. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20072 · Cited by 4
Abramov, A., Costa, J. A., Rosen, J., Asija, R., Benvenuto, L. J., Magda, G., Shah, L., Grewal, H. S., DiMango, A. M., Robbins, H., et al. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.09.024 · Cited by 4
Self-citationZarrabian, B., Pennington, K. M., Cajigas, H. R., DuBrock, H. M., Kennedy, C. C., Frantz, R. P., Kushwaha, S. S., Villavicencio, M. A., & Saddoughi, S. A. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.11.028 · Cited by 4
A Review of Anesthesia for Lung Transplantation
Kim, H.-J., Shin, S.-W., Park, S., & Kim, H. Y. (2022) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/jcs.22.046 · Cited by 4
“A high fraction of inspired oxygen after reperfusion is associated with PGD [39]; thus, it should be kept at a low enough level to keep arterial oxygen partial pressure above 70 mm Hg [40].”
BackgroundUpdate in lung transplantation: anesthetic considerations
Fritz, A. V., Teixeira, M. T., Patel, S. J., Burtoft, M. A., & Martin, A. K. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-4602 · Cited by 4
“The routine use of ECMO support following LTx has become a more standard practice in patients deemed high risk for development of acute PGD such as those with preexisting PH (72,73).”
Noda, K., Snyder, M. E., Xu, Q., Peters, D. G., McDyer, J. F., Zeevi, A., & Sánchez, P. G. (2024) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1339814 · Cited by 4
“Severe PGD is now appreciated to be a systemic condition which may impact the proportion of donor and recipient derived cfDNA (27).”
BackgroundEnvironmental Risk Factors for Acute Respiratory Distress Syndrome
Bennett, R. M., & Reilly, J. P. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.08.002 · Cited by 6
Chan, E. G., Deitz, R. L., Ryan, J. P., Suzuki, Y., Hage, C. A., Furukawa, M., Noda, K., Subramaniam, K., & Sánchez, P. G. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.09.055 · Cited by 4
Fluid Management in Lung Transplant Patients
Schultze, B. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.01.007 · Cited by 4
“A history of idiopathic pulmonary fibrosis, pulmonary arterial hypertension, significant smoking, and increased body mass index have been associated with worse outcomes and the development of PGD.7,9 The management of the donor patient before explantation of lungs is likely to directly influence the outcome of the tra…”
BackgroundInfluentialŞenbaklavacı, Ö. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.03.055 · Cited by 4
Anesthetic considerations for lung transplantation
Yoo, Y. C. (2019) · Anesthesia and Pain Medicine · doi:10.17085/apm.2019.14.3.241 · Cited by 4
Lung Transplantation and Precision Medicine
Beeckmans, H., Sáez, B., Herck, A. V., Sacreas, A., Kaes, J., Heigl, T., Vanstapel, A., Ordies, S., Frick, A. E., Verleden, S. E., et al. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_22 · Cited by 4
Practical considerations for developing a lung transplantation anesthesiology program
Fritz, A. V., Martin, A. K., & Ramakrishna, H. (2021) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-021-01217-x · Cited by 4
Postoperative Respiratory Failure and Treatment
Smith, W., Finley, A. C., & Ramsay, J. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-00859-8_54 · Cited by 4
Ethical Issues in Organ Transplantation
Ramos, H. C., & McCauley, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-19617-6_26 · Cited by 4
Washington, G. C., O’Donnell, C. T., Madhok, J., Williams, K. M., & Hill, C. C. (2023) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_276_20 · Cited by 4
“Several studies have found that patients with PAH have a higher risk of primary graft dysfunction.[16] Though our study includes a few patients with a concomitant diagnosis of World Health Organization (WHO) group 3 PAH, there were no patients with WHO Group 1 PAH.”
Potential Role of Computed Tomography Volumetry in Size Matching in Lung Transplantation
Guillamet, R. V., Rjob, A., Bierhals, A. J., Tague, L. K., Marklin, G. F., Halverson, L. P., Witt, C. A., Byers, D. E., Hachem, R. R., Gierada, D. S., et al. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.02.016 · Cited by 4
Oishi, H., Okada, Y., Suzuki, Y., Hirama, T., Ejima, Y., Fujimaki, S., Sugawara, S., Okubo, N., & Horiuchi, H. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-275 · Cited by 4
The role of lung microbiota in primary graft dysfunction in lung transplant recipients
Wu, Y., Huang, L., Li, M., Cui, X., Zhan, Q., & Wang, C. (2023) · Clinical Transplantation · doi:10.1111/ctr.15152 · Cited by 5
Methangkool, E., Mahajan, A., Gao, G., & Chua, J. H. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.05.033 · Cited by 4
Soresi, S., Zeriouh, M., Sabashnikov, A., Sarang, Z., Mohite, P. N., Patil, N. P., Mansur, A., Weymann, A., Wippermann, J., Wahlers, T., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.11.068 · Cited by 4
Aryl-Hydrocarbon Receptor Repressor Gene in Primary Graft Dysfunction After Lung Transplantation
Anderson, M. R., Edwin, E. A., Diamond, J. M., Ferrante, A. W., Sonett, J. R., D’Ovidio, F., Arcasoy, S. M., Cantu, E., Christie, J. D., & Lederer, D. J. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0404le · Cited by 4
Self-citationOvercoming Primary Graft Dysfunction After Lung Transplantation
Bertani, A. (2014) · Transplantation · doi:10.1097/tp.0000000000000033 · Cited by 4
Statins in lung transplantation: A treatment option for every patient?
Verleden, G. M., & Vos, R. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.05.027 · Cited by 4
Pascreau, T., Gougeon, M., Fessler, J., Chahabi, S. Z., Guen, M. L., & Vasse, M. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.11.029 · Cited by 3
Yuan, S., Zhou, Y., Chen, J., Zhang, X., & Wang, G. (2024) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-024-00050-w · Cited by 4
Koyama, T., Zhao, Z., Balmes, J. R., Calfee, C. S., Matthay, M. A., Reilly, J. P., Porteous, M. K., Diamond, J. M., Christie, J. D., Cantu, E., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.07.003 · Cited by 3
Self-citationKurihara, C., Kaiho, T., Thomae, B. L., Cerier, E. J., Lung, K. C., Patino, D. M. A., Toyoda, T., Yan, Y., Budinger, G. R. S., & Bharat, A. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-100 · Cited by 3
“The existing body of research on lung transplantation and PGD has identified several risk factors, such as prolonged ischemic time and the use of intraoperative cardiopulmonary bypass (4-11).”
Hauser, B. R., Estafanos, M., Ayyat, K. S., Yun, J. J., & Elgharably, H. (2024) · Expert Review of Medical Devices · doi:10.1080/17434440.2024.2442485 · Cited by 3
“Arguably, the most predominant early barrier to successful LTx is primary graft dysfunction (PGD), defined as hypoxemia in the setting of pulmonary infiltrates on chest x-ray, which impacts lung recipients within the first 72 hours post-transplant [3,4].”
Freund, J. C., Gosalvez, C. C., Rady, A., Notarianni, A. P., & Carr, Z. J. (2025) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-025-00087-5 · Cited by 3
Therapeutic options for patients with pulmonary hypertension and interstitial lung disease
Swisher, J. W., & Weaver, E. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251335815 · Cited by 3
Pan, J., Zhang, J., & Lu, X. (2025) · Surgery Today · doi:10.1007/s00595-025-03129-4 · Cited by 6
“A total of 61 studies with 59,865 patients who underwent LT were included [5–7, 13, 15, 18, 19, 26–31].”
InfluentialFessler, J., Ma, W., Martin, A. K., Bottiger, B., Neyrinck, A., Jacqmin, S., Guen, M. L., & Marczin, N. (2025) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2025.112026 · Cited by 3
Kotloff, R. M., & Keshavjee, S. H. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00106-8 · Cited by 3
Hirdman, G., Niroomand, A., Olm, F., & Lindstedt, S. (2022) · Current Transplantation Reports · doi:10.1007/s40472-022-00367-0 · Cited by 3
The Future of Cardiothoracic Surgical Critical Care Medicine as a Medical Science: A Call to Action
Kopanczyk, R., Lester, J., Long, M. T., Kossbiel, B. J., Hess, A. S., Rozycki, A. J., Nunley, D. R., Habib, A., Taylor, A., Awad, H., et al. (2022) · Medicina · doi:10.3390/medicina59010047 · Cited by 5
Girgis, R. E., Hadley, R. J., & Murphy, E. T. (2023) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2023.18 · Cited by 6
Siddiqui, A. S., & Shakil, J. (2024) · Annals of Transplantation · doi:10.12659/aot.943652 · Cited by 3
“Some of the common risk factors to predict the risk of developing PGD include the lung donor’s smoking/tobacco use, alcohol use, level of obesity, time on cardiopulmonary bypass/ ischemia time, and a higher degree of pre-existing pulmonary hypertension [27,28].”
BackgroundAnalysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients
Kubisa, M. J., Wojtyś, M. E., Lisowski, P., Kordykiewicz, D., Piotrowska, M., Wójcik, J., Pieróg, J., Safranow, K., Grodzki, T., & Kubisa, B. (2024) · Clinics and Practice · doi:10.3390/clinpract14040127 · Cited by 3
“With changes in organ preservation strategies, intraoperative support, and perioperative care, some previously recognized factors for PGD development—such as donor age, single lung transplantation, and intraoperative use of CBP—are becoming less significant [13,18,20].”
BackgroundLung Transplantation From Donors With a History of Substance Use
Li, D., Weinkauf, J. G., Hirji, A. S., Weatherald, J. C., Varughese, R. A., van den Bosch, L., Lien, D. C., Nagendran, J., & Halloran, K. M. (2025) · Clinical Transplantation · doi:10.1111/ctr.70162 · Cited by 3
“This holds true in the immediate post-transplant period, where a consistent association between heavy donor smoking and PGD3 has been shown, including our previous work [11, 12, 27].”
Respiratory Viruses at Time of Lung Transplant and the Relationship to Primary Graft Dysfunction
van den Bosch, L., Kaur, K., Varughese, R. A., Hirji, A. S., Weatherald, J. C., Weinkauf, J. G., Lien, D. C., Fernández‐García, O. A., Cervera, C., Doucette, K. E., et al. (2025) · Transplant Infectious Disease · doi:10.1111/tid.70078 · Cited by 4
“Several risk factors for PGD have been identified, including donor, recipient, perioperative, and posttransplant features, but the degree to which infection contributes is less clear, with previous work focusing mainly on bacteria [9, 10, 13–16].”
Fernandez, R., Ius, F., Reyes, J. E. M., de Manna, N. D., León-Peña, A. A., Hartwig, M. G., Ghadimi, K., Langer, N. B., Osho, A. A., Kashem, M. A., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.09.025 · Cited by 4
Ramesh, B. C., Andreasson, A. S. I., & Dark, J. H. (2014) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivu007 · Cited by 3
Critical Care of the Lung Transplant Patient
Perez, A. A., & Shah, R. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.04.007 · Cited by 4
Self-citationSiamwala, J. H., Mossman, J. A., Schorl, C., Borgas, D. L., Sakhatskyy, P. V., Rand, D. M., Lü, Q., & Rounds, S. (2023) · Physiological Genomics · doi:10.1152/physiolgenomics.00152.2022 · Cited by 3
Henry, J. P., Carlier, F. M., Higny, J., Benoît, M., Xhaët, O., Blommaert, D., Telbis, A.-M., Robaye, B., Gabriël, L., Guédès, A., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14131340 · Cited by 4
“The presence of pulmonary hypertension (PH) recently emerged as an important risk factor for developing PGD [4,9].”
BackgroundInfluentialLung Transplantation in Interstitial Lung Disease
Kim, C., CORDOVA, F. C., & Toyoda, Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-49918-5_5 · Cited by 3
Farooki, A. M., Cuschieri, H. B., Gordon, E. K. B., Lee, J. C., Cantu, E., & Augoustides, J. G. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.02.021 · Cited by 3
“PGD is the clinical manifestation of ischemia-reperfusion injury and is a common cause of perioperative mortality in LTX.(2,3,16,17) PGD contributes to early mortality, increased length of stay, increased ICU care, and increased cost.”
InfluentialSelf-citationPulmonary Fibrosis in Sarcoidosis
Carmona, E. M., Francesqui, J., & Kalra, S. (2021) · Barcelona Respiratory Network · doi:10.23866/brnrev:2021-m0066 · Cited by 4
Anesthetic Management During Lung Transplantation – What’s New in 2021?
Brzeziński, M., Mladinov, D., & Neyrinck, A. (2022) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2022.01.001 · Cited by 4
Outpatient Pharmacologic Management of Lung Transplant Candidates on the Waiting List
Sayah, D. M., & Pilewski, J. M. (2022) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2022.01.002 · Cited by 4
Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation
Mao, W., Xia, W. G., & Chen, J. (2014) · CHEST Journal · doi:10.1378/chest.13-1957 · Cited by 3
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.